Emergency medical services transport a 28-year-old female patient to the resuscitation bay due to an uninterrupted generalized tonic-clonic seizure. According to paramedic transport records, the active seizing started 15 minutes prior to arrival and has not abated. The patient remains unresponsive. Point-of-care blood glucose testing is 95 mg/dL. Bilateral large-bore intravenous catheters are secured.
Arrange the following pharmacologic interventions in the standard, guideline-concordant sequence for escalating the management of this patient's condition.
- 1Administer intravenous lorazepam
- 2Administer intravenous levetiracetam
- 3Initiate continuous intravenous propofol infusion
Answer
The correct sequence of pharmacologic escalation is to first administer intravenous lorazepam, followed by intravenous levetiracetam, and finally initiate a continuous intravenous propofol infusion if the seizures remain refractory.
The established protocol for status epilepticus management follows a strictly defined timeline. The initial therapy phase (0-20 minutes) requires an emergent benzodiazepine such as intravenous lorazepam to rapidly halt the seizure. The second therapy phase (20-40 minutes) involves administering a long-acting antiepileptic drug, such as intravenous levetiracetam, fosphenytoin, or valproic acid, to prevent recurrence. If seizures persist into the third therapy phase (>40 minutes), the condition is termed refractory status epilepticus, and treatment must escalate to continuous infusions of general anesthetics like propofol, midazolam, or pentobarbital alongside mechanical ventilation.
Step-by-Step Solution
Key Concept
The standard pharmacologic escalation for generalized convulsive status epilepticus progresses sequentially from an emergent intravenous benzodiazepine, to a long-acting non-benzodiazepine antiepileptic drug, and finally to a continuous infusion of a general anesthetic if the condition becomes refractory.
Estimated Time:1m 0s